Marco Busso1, Diego Sardo2, Irene Garetto2, Luisella Righi3, Giulia Libero2, Tiziana Vavalà4, Francesco Ardissone5, Silvia Novello4, Mauro Papotti3, Andrea Veltri2. 1. Radiology Unit, Department of Oncology, University of Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy. busso.marco@gmail.com. 2. Radiology Unit, Department of Oncology, University of Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy. 3. Pathology Unit, Department of Oncology, University of Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy. 4. Pulmonary Oncology Unit, Department of Oncology, University of Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy. 5. Thoracic Surgery Unit, University of Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
Abstract
OBJECTIVE OF THE STUDY: To identify risk factors for the adverse events and determine the diagnostic yield of a large series of image-guided thoracic biopsies performed in a single institution. MATERIALS AND METHODS: We reviewed a consecutive series of 811 patients (546 males; average age: 68 years.) who underwent 824 image-guided biopsies of pulmonary lesions performed between 2009 and 2013. Indications for biopsy were always evaluated by a multidisciplinary board. All complications were registered. The diagnostic accuracy was calculated on the basis of histology after surgery, response to medical therapy, or outcome at imaging follow-up. Safety and accuracy was correlated with patient-related and lesion-related factors. RESULTS: 61 biopsies were performed under US-guidance, 750 under CT-guidance, and 13 under combined guidance. The average lesion size was 36.4 mm (6-150 mm). FNAB was exclusively performed in 247 patients, whereas 577 patients underwent also or only core biopsy (CB). 40 (4.8 %) major complications and 172 (20.8 %) minor complications occurred. US-guidance, absence of perilesional emphysema and minor depth of the target lesion from the skin resulted as favorable predictors against major complications. According to the gold standard criteria, we demonstrated 497 true positives, 72 true negatives, 18 false negatives, 0 false positives. Sensitivity, specificity and diagnostic accuracy were 96.5, 100 and 97 %. No predictors for accuracy were found, but the number of samples largely related to the pathologist on site. CONCLUSIONS: Image-guided lung biopsy is safe and highly accurate for diagnosing thoracic lesions. In the targeted therapy era, CB with larger needles can be safely applied when the need for larger amounts of tumor tissue is presumed.
OBJECTIVE OF THE STUDY: To identify risk factors for the adverse events and determine the diagnostic yield of a large series of image-guided thoracic biopsies performed in a single institution. MATERIALS AND METHODS: We reviewed a consecutive series of 811 patients (546 males; average age: 68 years.) who underwent 824 image-guided biopsies of pulmonary lesions performed between 2009 and 2013. Indications for biopsy were always evaluated by a multidisciplinary board. All complications were registered. The diagnostic accuracy was calculated on the basis of histology after surgery, response to medical therapy, or outcome at imaging follow-up. Safety and accuracy was correlated with patient-related and lesion-related factors. RESULTS: 61 biopsies were performed under US-guidance, 750 under CT-guidance, and 13 under combined guidance. The average lesion size was 36.4 mm (6-150 mm). FNAB was exclusively performed in 247 patients, whereas 577 patients underwent also or only core biopsy (CB). 40 (4.8 %) major complications and 172 (20.8 %) minor complications occurred. US-guidance, absence of perilesional emphysema and minor depth of the target lesion from the skin resulted as favorable predictors against major complications. According to the gold standard criteria, we demonstrated 497 true positives, 72 true negatives, 18 false negatives, 0 false positives. Sensitivity, specificity and diagnostic accuracy were 96.5, 100 and 97 %. No predictors for accuracy were found, but the number of samples largely related to the pathologist on site. CONCLUSIONS: Image-guided lung biopsy is safe and highly accurate for diagnosing thoracic lesions. In the targeted therapy era, CB with larger needles can be safely applied when the need for larger amounts of tumor tissue is presumed.
Authors: A Manhire; M Charig; C Clelland; F Gleeson; R Miller; H Moss; K Pointon; C Richardson; E Sawicka Journal: Thorax Date: 2003-11 Impact factor: 9.139
Authors: Liang Cheng; Riley E Alexander; Gregory T Maclennan; Oscar W Cummings; Rodolfo Montironi; Antonio Lopez-Beltran; Harvey M Cramer; Darrell D Davidson; Shaobo Zhang Journal: Mod Pathol Date: 2012-01-27 Impact factor: 7.842
Authors: J L Swischuk; F Castaneda; J C Patel; R Li; K W Fraser; T M Brady; R E Bertino Journal: J Vasc Interv Radiol Date: 1998 Mar-Apr Impact factor: 3.464
Authors: Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward Journal: Carcinogenesis Date: 2009-11-24 Impact factor: 4.944
Authors: Kum Ju Chae; Hyunsook Hong; Soon Ho Yoon; Seokyung Hahn; Gong Yong Jin; Chang Min Park; Jin Mo Goo Journal: Sci Rep Date: 2019-08-27 Impact factor: 4.379